These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 13366536)

  • 21. [Clinical trials with 1-hydrazinophthalazine and with 1,4-dihydrazinophthalazine in arterial hypertension].
    VIOLANTI A
    Minerva Med; 1954 Dec; 45(98):1529-33. PubMed ID: 13235522
    [No Abstract]   [Full Text] [Related]  

  • 22. [Psychotropic drugs in the therapy of hypertension: repercussions in social medicine].
    Cittadini A
    Minerva Med; 1969 Jul; 60(53):2605-7. PubMed ID: 5794589
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapy of essential arterial hypertension. IV. Drugs with peripheral sympathetic action].
    Fossati C
    Clin Ter; 1980 May; 93(4):457-79. PubMed ID: 6106537
    [No Abstract]   [Full Text] [Related]  

  • 24. [Medicamentous treatment of hypertension with a Rauwolfia phthalazin combination compound (adelphan); preliminary report].
    BOHNER E; THEOBALD H
    Dtsch Med Wochenschr; 1955 Jun; 80(24):929-30. PubMed ID: 14391039
    [No Abstract]   [Full Text] [Related]  

  • 25. [On several anti-hypertensive drugs with special reference to the association of dihydroergocristine, reserpine and clopamide].
    Martinetti L; Lai G
    Arch Maragliano Patol Clin; 1970; 26(3):209-18. PubMed ID: 5002193
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of autonomic dysfunction with dermatological symptoms].
    KARCHER KH
    Med Klin; 1956 Oct; 51(43):1826-7. PubMed ID: 13386809
    [No Abstract]   [Full Text] [Related]  

  • 27. [Investigation of the renal effect of hypotensive drugs in hypertensive pregnancy toxemias].
    HAUSER GA; BAUMGARTNER R
    Gynaecologia; 1957 Apr; 143(4):275-85. PubMed ID: 13448489
    [No Abstract]   [Full Text] [Related]  

  • 28. [Possibilities and limitations of hypertensive therapy].
    Kaufmann W; Helber A
    Med Welt; 1974 Dec; 25(49):2065-71. PubMed ID: 4444503
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical test using a new anti-hypersensitive agent of DCR-515].
    Amarante A; Levy S
    Hospital (Rio J); 1969 Apr; 75(4):1409-19. PubMed ID: 5306430
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effects of peripheral circulation of reserpine and 2 (N-m-oxyphenylaminoethyl)-imidazoline in normal and arteriopathic subjects].
    IULIANI G; RODRIQUEZ G
    Riforma Med; 1958 Aug; 72(32):896-8. PubMed ID: 13579968
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of sympatholytic and vasodilator drugs.
    Moyer JH
    Pa Med; 1984 Jan; 87(1):34-42. PubMed ID: 6144088
    [No Abstract]   [Full Text] [Related]  

  • 32. The effects of reserpine on hypertensive patients over a period of two years.
    HODGKINSON R
    Br Heart J; 1956 Oct; 18(4):523-8. PubMed ID: 13374159
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pharmacotherapy of arterial hypertension].
    Gessler U; Pilgrim R
    Fortschr Med; 1977 Aug; 95(31):1912-5. PubMed ID: 892686
    [No Abstract]   [Full Text] [Related]  

  • 34. [Results in the therapy of hypertension with reserpine, dihydrazinophthalazine, a combination of both and placebos].
    BENGOLEA A; BASTAROLI J
    Prensa Med Argent; 1959 Jul; 46():1701-6. PubMed ID: 13798865
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of gestosis by new hypotensive drugs].
    TALAS M; HECZKO P; VASKOVA M
    Cas Lek Cesk; 1957 Jan; 96(3):83-6. PubMed ID: 13413892
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of late gestosis with hypotensive drugs].
    BECK L
    Geburtshilfe Frauenheilkd; 1957 Nov; 17(11):1010-23. PubMed ID: 13490711
    [No Abstract]   [Full Text] [Related]  

  • 37. [Electrolyte shifts in the vascular wall and myocardium under the effect of sympatholytics in experimental renal hypertension].
    Tumanov VA
    Vrach Delo; 1975 Jun; (6):76-8. PubMed ID: 1154747
    [No Abstract]   [Full Text] [Related]  

  • 38. [Content of isolated & combined short-term reserpine & dihydrazinophthalazine administration in circulatory hypertensive diseases].
    POLAK F; MENCIK Z
    Dtsch Gesundheitsw; 1958 Jul; 13(27):843-7. PubMed ID: 13585927
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of reserpine and dihydrazinophthalazine on cerebrospinal fluid and blood catecholamines in the hypertensive disease.
    Ciplea A; Bubuianu G
    Rev Roum Physiol; 1969; 6(4):267-74. PubMed ID: 4926779
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of hypertensive patients with adelphan-esidrex].
    Shvedenko LA; Parashchak AP; Ryzhova VL
    Klin Med (Mosk); 1983 Aug; 61(8):24-8. PubMed ID: 6358666
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.